Searched for
NEUROPATHIC PAIN
Pregabalin moved to Schedule H1 as centre cracks down on drug misusePregabalin, a nerve pain medication, now faces stricter controls. The Union health ministry has moved it to Schedule H1. This change aims t...- Drug misuse: Govt may curb 'Pregabalin' salesThe government is looking to control the sale of Pregabalin. This common medicine is being misused. The government wants to make sure it is...
- 46-year-old’s mysterious facial pain solved, Salman Khan battled it too: Apollo doctor decodes rare condition causing thisA 46-year-old man who suffered sharp, recurring pain on one side of his face for a year was diagnosed with secondary trigeminal neuralgia, ...
- The painkiller used for just about anythingGabapentin, approved for seizures and postherpetic neuralgia, has become widely used off-label for ailments like fibromyalgia, neuropathy, ...
- Two painkillers Tapentadol and Pregabalin may go off OTC over misuseThe Drugs Controller General of India (DCGI) is considering banning over-the-counter (OTC) sales of pain relievers Tapentadol and Pregabali...
- No, cannabis cannot treat pain! New research debunks most common reason cited by usersThe study also revealed many participants can distinguish between a placebo and active cannabis.
- Dealing with constant headaches? Blame it on excessive tensionTension headache is different from migraine.
- Your six-step guide to FibromyalgiaFibromyalgia is a common ailment characterised by chronic widespread pain and a heightened and painful response to pressure.
- 'Off switch' for pain discovered in the brainScientists have discovered that it is possible to block a pathway in the brain of animals suffering from neuropathic pain, which could have...
- 'Off switch' for pain discovered in the brainCurrent treatments are problematic because they cause intolerable side effects, diminish quality of life and do not sufficiently quell pain.
- Cadila Healthcare, Zydus Pharmaceuticals to settle patent infringement case with Depomed IncThe settlement will allow Cadila and Zydus to begin sell of generic versions of Gralise on January 1, 2024, or earlier under certain circum...
- Sun Pharma gets USFDA nod for anti-depressant drugThe company said its subsidiary has received nod from the US Food and Drug Administration to market Duloxetine Delayed-Release Capsules.
- Glenmark Pharmaceuticals Q2 net up nearly three fold at Rs 156.75 crGlenmark Pharmaceuticals today said its consolidated net profit rose by nearly three fold to Rs 156.75 crore for the quarter ended Septembe...
- Lupin gets USFDA approval for generic version of LyricaDrug firm Lupin today said it has received approval from the US health regulator to market generic version of Lyrica in the American market.
- Lupin gets tentative USFDA approval for Pregabalin; stk upLupin’s subsidiary Lupin Pharmaceuticals Inc has received tentative ANDA approval for its Pregabalin capsules from the USFDA.
- Glenmark molecule enters human trials;stk upGlenmark Pharmaceuticals has announced that its novel molecule 'GRC 17536' for pain and respiratory is entering human trials.
- Glenmark Pharma to develop GRC 15300Glenmark Pharmaceuticals has registered its candidate GRC 15300, for osteoarthritic pain, neuropathic pain, and other inflammatory pain con...
- Glenmark's neuropathic drug candidate ready for trialsDrug maker Glenmark Pharmaceuticals said its candidate for neuropathic, osteoarthritis and other inflammatory pain GRC 10693, is entering p...
- Glenmark to enter Europe with Rs 100 crore buyLeading mid-sized pharma company Glenmark Pharmaceuticals would soon enter the European market by acquiring a front-end pharmaceutical comp...
- Foreign players look at India to develop lower-cost drugsGerman pharma major Boehringer Ingelheim is close to completing its first in-licensing deal with an Indian pharmaceutical company.
Load More
